Cargando…
A predictive nomogram of bleeding risk in patients with atrial fibrillation after drug-eluting stent implantation
BACKGROUND: The use of anticoagulants and antiplatelet therapies is associated with a higher risk of bleeding in atrial fibrillation (AF) patients after percutaneous coronary intervention, especially after stent implantation. However, no accurate bleeding risk prediction tool has been developed for...
Autores principales: | Qian, Jun, Zan, Jiyong, Kuang, Lijun, Che, Lin, Yu, Yunan, Shen, Ting, Tang, Jiani, Chen, Fei, Liu, Xuebo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940957/ https://www.ncbi.nlm.nih.gov/pubmed/33708820 http://dx.doi.org/10.21037/atm-20-3971 |
Ejemplares similares
-
Prognosis and management of new‐onset atrial fibrillation in critically ill patients
por: Qian, Jun, et al.
Publicado: (2021) -
Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011) -
Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
por: Voudris, Vassilis, et al.
Publicado: (2014) -
The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010) -
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
por: Arat Ozkan, Alev, et al.
Publicado: (2016)